Plain-English translation of NCT06865417 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ulcerative Colitis research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called to see if it can help children and teenagers with ulcerative colitis — a condition that causes inflammation and bleeding in the colon. Researchers want to learn whether the medication is safe, well-tolerated, and effective at reducing symptoms like diarrhea, rectal bleeding, and belly pain. The medication works by calming down the immune system's overactive response that damages the gut.
Many children with ulcerative colitis don't respond well to current treatments, or they develop side effects that make it hard to keep taking them. This trial is testing whether this new treatment could offer a better option for young patients who need help managing their disease.
You likely qualify if…
You likely don't qualify if…
You will take the medication by mouth each morning for up to 22 weeks. You'll visit the study site at weeks 4, 10, and 22 to take the medication there and be checked by the study team; on all other days, you'll take it at home. The doctors will monitor how well the medication is working and watch for any side effects through blood tests, clinic visits, and symptom assessments.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Belgium
Croatia